Table 2.

Summary of 18 patients with recurrent ischemic stroke.

No	Age at symptom onset (years)	Vascular risk factor	mRS score at baseline	Initial symptom	Outcome
					Recurrent ischemic event	Internal (months)	Functional status	Bleeding event
Untreated group (n = 11)
1	36–40	None	>2	Cerebral infarction	Cerebral infarction	5	Good	No
2	20–25	Hypertension	>2	Cerebral infarction	Cerebral infarction	26	Good	No
3	26–30	Hypertension	>2	Cerebral infarction	Cerebral infarction	64	Good	No
4	20–25	None	>2	Cerebral infarction	Cerebral infarction	50	Good	No
5	36–40	None	>2	Cerebral infarction	Cerebral infarction	31	Good	No
6	46–50	Hypertension	0–2	Cerebral infarction	Cerebral infarction	5	Good	No
7	30–35	Smoking, drinking	>2	Cerebral infarction	Cerebral infarction	44	Poor	No
8	46–50	None	>2	Cerebral infarction	Cerebral infarction	6	Poor	No
9	56–60	Hypertension, diabetes	0–2	Cerebral infarction	Cerebral infarction	20	Poor	No
10	50–55	None	>2	Cerebral infarction	Cerebral infarction	6	Poor	No
11	56–60	Hypertension, diabetes	0–2	Cerebral infarction	Cerebral infarction	33	Good	No
Antiplatelet group (n = 6)
1	40–45	Hypertension, hyperlipidemia	>2	Cerebral infarction	Cerebral infarction	65	Poor	Cerebral hemorrhage
2	50–55	Smoking	0–2	Cerebral infarction	Cerebral infarction	13	Poor	No
3	36–40	None	>2	Cerebral infarction	Cerebral infarction	58	Poor	Cerebral hemorrhage
4	56–60	Hypertension, diabetes, smoking	0–2	Cerebral infarction	Cerebral infarction	63	Good	No
5	30–35	Hyperlipidemia	>2	Cerebral infarction	Cerebral infarction	16	Poor	No
6	56–60	Hypertension, diabetes, drinking	>2	Cerebral infarction	Cerebral infarction	64	Poor	No
Surgical group (n = 1)
1	20–25	None	>2	Cerebral infarction	Cerebral infarction	72	Poor	No